MT SB317

Health insurance issuers are prohibited from requiring prior authorization for psychiatric prescription drugs that are designated as in shortage by the FDA

The list of shortage psychiatric drugs is updated quarterly (April 1, July 1, October 1, January 1) based on the official FDA drug shortage list, with each quarterly list remaining in effect until the next update date

Drug manufacturers are prohibited from engaging in predatory pricing or marketing related to any shortage of these psychiatric medications, with violations subject to enforcement under Montana's unfair trade practices laws (Title 30, chapter 14, part 1)

Amends existing Montana law (Section 33-32-221, MCA) that already prohibits prior authorization for certain drugs including long-acting injectable antipsychotics and generic drugs after 6 months of continuous use